making innovation happen, together

linkedin.com

Financial results

2020 consolidated results

Consolidated Income Statement Data
(Thousands of euro)

2020

2019
Total net sales 168,703 182,352
Gross profit 70,113 78,373
% on sales 41.6% 43.0%
Operating income 16,274 26,772
% on sales 9.6% 14.7%
EBITDA 27,225 36,502
% on sales 16.1% 20.0%
Net income (loss) from continued operations 4,787 19,685
% on sales 2.8% 10.8%
Income (loss) from discontinued operations 0 152
% on sales 0.0% 0.1%
Group net income 4,787 19,837
% on sales 2.8% 10.9%
 
Consolidated Balance Sheet Data
(Thousands of euro) December 31, 2020 December 31, 2019
Group shareholders' equity 238,162 252,530
Net financial position 95,742 115,316
MARGINS SUBSTANTIALLY STABLE, DESPITE THE EFFECT OF COVID-19 AND INTERNATIONAL TENSIONS, RESPECTIVELY IN THE MEDICAL SECTOR AND IN SMA FOR INDUSTRIAL APPLICATIONS
 
PENALIZING EXCHANGE EFFECT IN THE SECOND HALF OF THE YEAR
 
RECOVERY SIGNS IN THE MEDICAL SECTOR STARTING FROM THE LAST PART OF THE YEAR
 
  • Consolidated net revenues equal to €168.7 million compared to €182.4 million in FY 2019; net of the negative exchange rate effect (-1.3%), organic decrease equal to -6.2%
  • Total revenues of the Group equal to €177.7 million compared to €194 million in FY 2019
  • Consolidated gross profit equal to €70.1 million compared to €78.4 million in FY 2019
  • Gross margin equal to 41.6% of revenues, substantially stable compared to 43% of revenues in FY 2019
  • Consolidated operating income equal to €16.3 million compared to €26.8 million in FY 2019
  • Consolidated EBITDA equal to €27.2 million (16.1% of revenues) compared to €36.5 million (20% of revenues) in FY 2019
  • Donations for Covid-19 to hospitals, research institutions and Civil Protection equal to €0.7 million in FY 2020
  • Financial management penalized by write-downs totaling €3.6 million (write-downs equal to €1.6 million in FY 2019)
  • Consolidated net income equal to €4.8 million compared to €19.8 million in FY 2019
  • Net financial position positive and equal to €95.7 million, improved when compared to €94 million at September 30, 2020
  • Proposed a dividend of €0.4 per ordinary share and of €0.424378 per savings share, by distribution of both net income and retained earnings
  • Consolidated revenues equal to €26.5 million in the first two months of 2021, compared to €32.4 million in the first two months of 2020

 

Financial results

Stay tuned to Saes Getters latest
Financial information

Register today

to receive our new newsletter service